Literature DB >> 21639855

Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains.

Leila Hejazi1, Jason W H Wong, Danni Cheng, Nicholas Proschogo, Diako Ebrahimi, Brett Garner, Anthony S Don.   

Abstract

Current lipidomic profiling methods rely mainly on MS to identify unknown lipids within a complex sample. We describe a new approach, involving LC×MS/MS (liquid chromatography×tandem MS) analysis of sphingolipids based on both mass and hydrophobicity, and use this method to characterize the SM (sphingomyelin), ceramide and GalCer (galactosylceramide) content of hippocampus from AD (Alzheimer's disease) and control subjects. Using a mathematical relationship we exclude the influence of sphingolipid mass on retention time, and generate two-dimensional plots that facilitate accurate visualization and characterization of the different ceramide moieties within a given sphingolipid class, because related molecules align horizontally or vertically on the plots. Major brain GalCer species that differ in mass by only 0.04 Da were easily differentiated on the basis of their hydrophobicity. The importance of our method's capacity to define all of the major GalCer species in the brain samples is illustrated by the novel observation that the proportion of GalCer with hydroxylated fatty acids increased approximately 2-fold in the hippocampus of AD patients, compared with age- and gender-matched controls. This suggests activation of fatty acid hydroxylase in AD. Our method greatly improves the clarity of data obtained in a lipid profiling experiment and can be expanded to other lipid classes. © The Authors Journal compilation
© 2011 Biochemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21639855     DOI: 10.1042/BJ20110566

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Edward Re; Lisa Longato; Ming Tong
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  A three-step assay for ceramide synthase activity using a fluorescent substrate and HPLC.

Authors:  Timothy A Couttas; Xin Y Lim; Anthony S Don
Journal:  Lipids       Date:  2014-11-18       Impact factor: 1.880

3.  High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma.

Authors:  Anne-Marie Lemay; Olivier Courtemanche; Timothy A Couttas; Giuleta Jamsari; Andréanne Gagné; Yohan Bossé; Philippe Joubert; Anthony S Don; David Marsolais
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

4.  Mass Spectrometric Analysis of Bioactive Sphingolipids in Fungi.

Authors:  Ashutosh Singh; Maurizio Del Poeta
Journal:  Methods Mol Biol       Date:  2021

5.  An improved high-throughput lipid extraction method for the analysis of human brain lipids.

Authors:  Sarah K Abbott; Andrew M Jenner; Todd W Mitchell; Simon H J Brown; Glenda M Halliday; Brett Garner
Journal:  Lipids       Date:  2013-01-26       Impact factor: 1.880

6.  A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.

Authors:  Hazem J Abuhusain; Azadeh Matin; Qiao Qiao; Han Shen; Nupur Kain; Bryan W Day; Brett W Stringer; Benjamin Daniels; Maarit A Laaksonen; Charlie Teo; Kerrie L McDonald; Anthony S Don
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

Review 7.  Lipid metabolism in Alzheimer's disease.

Authors:  Qiang Liu; Juan Zhang
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

8.  Human Brain Lipidomics: Utilities of Chloride Adducts in Flow Injection Analysis.

Authors:  Paul L Wood; Kathleen A Hauther; Jon H Scarborough; Dustin J Craney; Beatrix Dudzik; John E Cebak; Randall L Woltjer
Journal:  Life (Basel)       Date:  2021-04-28

9.  Lipidomics of Alzheimer's disease: current status.

Authors:  Paul L Wood
Journal:  Alzheimers Res Ther       Date:  2012-02-01       Impact factor: 6.982

10.  Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes.

Authors:  Yue Liu; Anbupalam Thalamuthu; Karen A Mather; John Crawford; Marina Ulanova; Matthew Wai Kin Wong; Russell Pickford; Perminder S Sachdev; Nady Braidy
Journal:  Transl Psychiatry       Date:  2021-06-07       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.